A synthetic peptide for use as a blocking control in assays to test for specificity of SLC29 A2 antibody, Alternative Names: SLC29A2 control peptide, SLC29A2 antibody Blocking Peptide, Anti-SLC29A2 Blocking Peptide, Solute Carrier Family 29 Member 2 Blocking Peptide, Nucleoside Transporters 2 Blocking Peptide, DER12 Blocking Peptide, ENT2 Blocking Peptide, HNP36 Blocking Peptide, SLC29A2, SLCA2-29, SLCA2 29, SLCA2-29 Blocking Peptide, SLCA2 29 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
SLC29A2
(Solute Carrier Family 29 (Nucleoside Transporters), Member 2 (SLC29A2))
Synonyme
DER12 Peptide, ENT2 Peptide, HNP36 Peptide, Der12 Peptide, Ent2 Peptide, Hnp36 Peptide, ent2 Peptide, der12 Peptide, hnp36 Peptide, MGC82995 Peptide, DKFZp468L038 Peptide, zgc:110527 Peptide, solute carrier family 29 member 2 Peptide, solute carrier family 29 (nucleoside transporters), member 2 Peptide, solute carrier family 29 (equilibrative nucleoside transporter), member 2 L homeolog Peptide, solute carrier family 29 (equilibrative nucleoside transporter), member 2 Peptide, SLC29A2 Peptide, Slc29a2 Peptide, slc29a2.L Peptide, slc29a2 Peptide
Hintergrund
SLC29A2 mediates equilibrative transport of purine, pyrimidine nucleosides and the purine base hypoxanthine. It is less sensitive than SLC29A1 to inhibition by nitrobenzylthioinosine (NBMPR), dipyridamole, dilazep and draflazine.